Definium Therapeutics, Inc.
For the period ended Jun 30, 2026. Filed Aug 6, 2026.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Jun 30, 2026 · Filed Aug 6, 2026
DFTX$35.39+6.4%Stored close · as of Nov 9, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Item 6. Exhibits
| ExhibitNumber · Description · Incorporated by Reference | |||||
|---|---|---|---|---|---|
| Form · Exhibit No. · Filing Date · File No. | |||||
| 3.1 | Amended and Restated Articles of Definium Therapeutics, Inc., effective as of January 9, 2026. | 10-K | 3.1 | February 26, 2026 | 001-40360 |
| 3.2 | Notice of Articles, Incorporated on July 26, 2010, effective as of January 29, 2026. | S-8 | 4.2 | June 16, 2026 | 001-296812 |
| 3.3 | Certificate of Name Change, dated January 9, 2026. | 8-K | 3.2 | January 12, 2026 | 001-40360 |
| 10.1*# | Form of Option Award Agreement under the Definium Therapeutics, Inc. 2026 Inducement Plan. | ||||
| 10.2# | Definium Therapeutics, Inc. 2026 Inducement Plan. | S-8 | 99.2 | June 16, 2026 | 001-296812 |
| 10.3# | Form of PSU Agreement under the Definium Therapeutics, Inc. 2025 Equity Incentive Plan. | 10-Q | 10.1 | May 7, 2026 | 001-40360 |
| 10.4# | Non-Employee Director Compensation Policy, amended as of April 15, 2026. | 10-Q | 10.2 | May 7, 2026 | 001-40360 |
| 10.5# | Amendment No. 1 to Definium Therapeutics, Inc. 2025 Equity Incentive Plan. | 8-K | 10.1 | June 12, 2026 | 001-40360 |
| 31.1* | Certification of Principal Executive Officer Pursuant to Rules 13a-14(a) and 15d-14(a) under the Securities Exchange Act of 1934, as Adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002. | ||||
| 31.2* | Certification of Principal Financial Officer Pursuant to Rules 13a-14(a) and 15d-14(a) under the Securities Exchange Act of 1934, as Adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002. | ||||
| 32.1*+ | Certification of Principal Executive Officer Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002. | ||||
| 32.2*+ | Certification of Principal Financial Officer Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002. | ||||
| 101.INS | Inline XBRL Instance Document – the instance document does not appear in the Interactive Data File because XBRL tags are embedded within the Inline XBRL document. | ||||
| 101.SCH | Inline XBRL Taxonomy Extension Schema with Embedded Linkbase Documents | ||||
| 104 | Cover Page Interactive Data File (embedded within the Inline XBRL document) | ||||
- Filed or furnished herewith.
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.